Error loading player: No playable sources found
73547
Session I: Molecular Design, Developability and Biotransformation
Date
September 6, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
Importance of Disulfide Bond re-arrangement in vitro and in vivo: Evidence and Approaches to Address It
Franta Hubálek, Novo Nordisk A/S
Development of a Rapid and Automated, Compliance Ready Workflow for Full Sequence Coverage of RNAi Therapeutics
Jennifer Nguyen, Alnylam Pharmaceuticals
Elucidation, Characterization and Monitoring of a Unique Tyrosine Sulfation Post-Translational Modification During Bispecific Antibody Process Development and Scaleup
David Mahon, Bristol-Myers Squibb Company
Importance of Disulfide Bond re-arrangement in vitro and in vivo: Evidence and Approaches to Address It
Franta Hubálek, Novo Nordisk A/S
Development of a Rapid and Automated, Compliance Ready Workflow for Full Sequence Coverage of RNAi Therapeutics
Jennifer Nguyen, Alnylam Pharmaceuticals
Elucidation, Characterization and Monitoring of a Unique Tyrosine Sulfation Post-Translational Modification During Bispecific Antibody Process Development and Scaleup
David Mahon, Bristol-Myers Squibb Company
Session Chairs
Related Products
The Regulator Panel: Can We Talk?
Featured Panelists:
Mass Spec 20th Anniversary Vendor Showcase ~ Presented by MOBILion Systems, Inc.
HOS attendees should grab their lunch and proceed to the meal room to eat…
Technical Seminar: Presented by GenNext Technologies, Inc.
Technical Seminar Lunch & Learn Sessions are for Mass Spec attendees only. HOS attendees and those not wishing to attend should grab their lunch and proceed to the Explore Room (Floor 2)…
Featured Joint Keynote Presentation: Hacking Structural Biology for Drug Delivery Using Protein Footprinting Based Mass Spectrometry
Joint Keynote Presenter Mark R. Chance Has a Message for You [https://www.youtube…
